5.4 C
Munich
Friday, April 4, 2025
type here...
Uncategorized

Sangamo Gets Lifeline From Eli Lilly In $1.4 Billion Dollar Deal For Proprietary AAV Capsid

pharmadigz_xixo9l -
It was just announced that Sangamo Therapeutics entered into a licensing agreement with Eli Lilly to advance a proprietary STAC-BBB AAV capsid. This is to be used by the...

Editor Picks

- Advertisement -spot_img

Business

New Podcast

Subscribe to our newsletter

To be updated with all the latest news, offers and special announcements.

Stay Connected

16,985FansLike
2,458FollowersFollow
61,453SubscribersSubscribe

Magazine

View All News

Politics
Latest

Uncategorized

Sangamo Gets Lifeline From Eli Lilly In $1.4 Billion Dollar Deal For Proprietary AAV Capsid

pharmadigz_xixo9l -
It was just announced that Sangamo Therapeutics entered into a licensing agreement with Eli Lilly to advance a proprietary STAC-BBB AAV capsid. This is...
Uncategorized

Second FDA Rejection Of Aldeyra Therapeutics But Hope Remains With Two Upcoming Events

pharmadigz_xixo9l -
It was announced today that Aldeyra Therapeutics had received a Complete Response Letter or CRL from the FDA of its drug reproxalap for the...
Uncategorized

Latest Corcept Data Could Lead To New Standard Of Care Option for Platinum-Resistant Ovarian Cancer Patients

pharmadigz_xixo9l -
Corcept Therapeutics is on a roll the last month, because it had been able to establish two key events from its pipeline. For starters,...
Uncategorized

Cassava Sciences Scraps Alzheimer’s Drug Development Of Simufilam After Latest Trial Failure

pharmadigz_xixo9l -
Cassava Sciences recently reported results from its second of two phase 3 studies known as REFOCUS-ALZ. This was a huge study as it recruited...
Uncategorized

Lexicon Establishes $1 Billion Milestone Deal With Novo Nordisk To Advance Weight Loss Drug LX9851

pharmadigz_xixo9l -
/ Lexicon Pharmaceuticals was able to establish a deal with Novo Nordisk, whereby the big pharma obtained an exclusive, worldwide license for LX9851 for the...

Sport

More from Sport
- Advertisement -spot_img

Culture

More from Culture

Must Read

Everything you need to know about the re-reboot of your favourite childhood flick.

- Advertisement -spot_img

Arts

Style
Latest

Uncategorized

Sangamo Gets Lifeline From Eli Lilly In $1.4 Billion Dollar Deal For Proprietary AAV Capsid

pharmadigz_xixo9l -
It was just announced that Sangamo Therapeutics entered into a licensing agreement with Eli Lilly to advance a proprietary STAC-BBB AAV capsid. This is to be used by the...
Uncategorized

Second FDA Rejection Of Aldeyra Therapeutics But Hope Remains With Two Upcoming Events

pharmadigz_xixo9l -
It was announced today that Aldeyra Therapeutics had received a Complete Response Letter or CRL from the FDA of its drug reproxalap for the...
Uncategorized

Latest Corcept Data Could Lead To New Standard Of Care Option for Platinum-Resistant Ovarian Cancer Patients

pharmadigz_xixo9l -
Corcept Therapeutics is on a roll the last month, because it had been able to establish two key events from its pipeline. For starters,...
Uncategorized

Cassava Sciences Scraps Alzheimer’s Drug Development Of Simufilam After Latest Trial Failure

pharmadigz_xixo9l -
Cassava Sciences recently reported results from its second of two phase 3 studies known as REFOCUS-ALZ. This was a huge study as it recruited...

Travel

More from Travel
- Advertisement -spot_img

News

More from News

© Munich, LLC. All rights reserved. Pulses Pro® is a registered U.S. trademark of tagDiv, LLC.

About Us

Popular Category

    Editor Picks